Clinical trial
Association Study Between CYP1A2 Gene Polymorphisms and Metabolism of Theophylline in Han and Uygur Patients With COPD
NCT03015090 is registered in ClinicalTrials.gov with XiaoGuang Zou as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Association Study Between CYP1A2 Gene Polymorphisms and Metabolism of Theophylline in Han and Uygur Patients With COPD
- Lead sponsor
- XiaoGuang Zou
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2017
- Completion date
- June 1, 2017
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease